YIDAO BIOTECHNOLOGY
Yidao Biotechnology research and develops vaccines and biomedical products. It focuses on the research and development of a variety of vaccines such as recombinant protein antigen vaccine, new virus vector vaccine, messenger RNA vaccine, and vaccine adjuvant platforms, providing vaccines to meet the needs of human health in both domestic and international markets. The Suzhou, Jiangsu-based biotech company was established in 2017.
YIDAO BIOTECHNOLOGY
Industry:
Biotechnology Health Care Life Science Pharmaceutical Product Research
Founded:
2017-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.immune-path.com
Status:
Active
Total Funding:
61.79 M USD
Similar Organizations
BVG Life Sciences
BVG Life Sciences is a research and development lab for human, plant and animal products.
Luxna Biotech
Luxana Biotech is established to contribute to medical treatment for suffering patients, .
Sana Biotechnology
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Current Employees Featured
Founder
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Yidao Biotechnology
Northern Light Venture Capital
Northern Light Venture Capital investment in Venture Round - Yidao Biotechnology
Official Site Inspections
http://www.immune-path.com
- Host name: 140.207.177.207
- IP address: 140.207.177.207
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
